REGENERON ONCOLOGY

Serial Number 97749337
733

Registration Progress

Application Filed
Jan 11, 2023
Under Examination
Jun 6, 2023
Approved for Publication
Apr 11, 2023
Published for Opposition
Apr 11, 2023
Registered

Attorney Assistance

Statement of Use Due - Extension 4 Granted
Due: Dec 06, 2025 113 days

Trademark Image

REGENERON ONCOLOGY

Basic Information

Serial Number
97749337
Filing Date
January 11, 2023
Published for Opposition
April 11, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
733
Status Date
May 10, 2025
Application
Pending
Classes
044

Rights Holder

Regeneron Pharmaceuticals, Inc.

03
Address
777 Old Saw Mill River Road
Tarrytown, NY 10591

Ownership History

Regeneron Pharmaceuticals, Inc.

Original Applicant
03
Tarrytown, NY

Regeneron Pharmaceuticals, Inc.

Owner at Publication
03
Tarrytown, NY

Legal Representation

Attorney
Terrence J. McAllister

USPTO Deadlines

Next Deadline
113 days remaining
Statement of Use Due - Extension 4 Granted
Due Date
December 06, 2025
Extension Available
Until June 06, 2024

Application History

32 events
Date Code Type Description Documents
Jun 30, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jun 30, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jun 30, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
May 10, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 10, 2025 EX4G S SOU EXTENSION 4 GRANTED Loading...
May 10, 2025 EXT4 S SOU EXTENSION 4 FILED Loading...
May 9, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 3, 2025 EX3G S SOU EXTENSION 3 GRANTED Loading...
Feb 3, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 31, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Nov 16, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 16, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
May 15, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 14, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
May 14, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
May 14, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 21, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 18, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 18, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 18, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jun 6, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 11, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 11, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 22, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 8, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 8, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Mar 8, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Mar 8, 2023 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Mar 8, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Mar 6, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 1, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 14, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 044
Providing information in the field of cancer research and treatment

Classification

International Classes
044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"ONCOLOGY"